Standardized sTudy With Almotriptan in eaRly Treatment of Migraine, START. An International, Open-Label, Single Arm, Effectiveness and Safety Study of Almotriptan in Primary Care Setting.
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2015
At a glance
- Drugs Almotriptan (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Acronyms START
- Sponsors Almirall S.A.
- 24 Mar 2012 This trial has recruiting in France.
- 09 Oct 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 09 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.